. Author manuscript; available in PMC: 2012 Aug 23.

Published in final edited form as: J Matern Fetal Neonatal Med. 2010 Aug;23(8):820–827. doi: 10.3109/14767050903366119

Table IV.

Comparison of the maternal plasma and serum concentrations of sVEGFR-1, sVEGFR-2, PlGF and sEng in patients with preeclampsia

Analyte	Plasma (n=34)	Serum (n=34)	p^*
sVEGFR-1 (pg/mL)	17,747.7 (5,557.8 – 58,140.6)	18,284.5 (5,955.4 – 70,199.1)	0.01
sVEGFR-2 (pg/mL)	6,668 (3,487.8 – 10,399.1)	7,298 (3,746.4 – 10,725.4)	<0.001
PlGF (pg/mL)	60.5 (6.8 – 250.5)	61.4 (6.8 – 289.9)	0.001
sEng (ng/mL)	35.9 (11.2 – 353.2)	39.1 (12 – 437.5)	0.005

The results are expressed as median (range)

Wilcoxon ranks test